Morning routines shape children’s readiness for learning, emotional balance and academic success. Research consistently shows that simple but intentional tweaks to these routines can substantially ...

It's conventional wisdom that having a college education can be an enormous advantage in terms of furthering your career—and the data backs that up. With a college degree, you're more likely to make a ...

The Toronto Blue Jays weren't expected to do much this season. After finishing 2024 in last place of the division, many pundits and analysts expected that to finish towards the bottom once again this ...

Brain-training games are all the rage, but whether they prevent cognitive decline has been debatable. Studies in recent years have gone back and forth on the topic, with no definitive conclusion.

While the size of your nest egg can help determine how comfortable you’ll be in retirement, so does where you choose to live. And some states do a better job of setting up residents for success in ...

It may be hard to believe, but 2026 is just around the corner. In the blink of an eye, 2025 has flown by, and the final stretch of the year is settling in. For people hoping to make the new year their ...

We may receive a commission on purchases made from links. Do you like hanging out in a pool of stagnant water? Think wet socks, or a half-clogged bathtub drain that fills the tub when you shower.

Jaxson Dart got the first start of his NFL career in the New York Giants’ 21-18 win against the Los Angeles Chargers. Statistically, he completed 13 of his 20 passes (65%) for 111 yards and one ...

A new study from Stanford University and AI coaching platform BetterUp has coined a new term for subpar AI-generated content: workslop. About 40% of the 1,150 workers surveyed in the study reported ...

Roche has set its sights on becoming a “top three” obesity company, according to the pharma’s long-awaited strategy for cracking the weight loss market. Addressing a conference room full of investors ...

UniQure has set its sights on submitting its Huntington’s disease gene therapy for approval next year after the asset was shown to slow progression of the neurodegenerative condition by 75% in a phase ...